Author:
Nemoto Kenji,Hayashihara Kenji,Oh-ishi Shuji,Nakazawa Mariko,Fujita Kazutaka,Sakurai Hirofumi,Kanazawa Jun,Shih-Yuan Lin,Takaku Takio,Minami Yuko,Saito Takefumi
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Weiss MJ, Edmondson HA, Wertman M (1951) Elevated serum amylase associated with bronchogenic carcinoma. Am J Clin Pathol 21:1057–1061
2. Ammann RW, Berk JE, Fridhandler L et al (1973) Hyperamylasemia with carcinoma of the lung. Ann Intern Med 78:521–525
3. Lenler-Petersen P, Grove A, Brock A et al (1994) Alpha-amylase in resectable lung cancer. Eur Respir J 7:941–945
4. Ko HW, Tsai YH, Yu CT et al (2008) Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report. Chang Gung Med J 31:606–611
5. Zhang J, Zhang L, Pan S et al (2013) Amylase: sensitive tumor marker for amylase-producing lung adenocarcinoma. J Thorac Dis 5:167–169